People with polycystic ovarian syndrome (PCOS) could be more at risk for eating disorders than people without PCOS, according to recent results from a review and meta-analysis published in the Journal of Clinical Endocrinology & Metabolism.
People with polycystic ovarian syndrome (PCOS) could be more at risk for eating disorders than people without PCOS, according to recent results from a review and meta-analysis published in the Journal of Clinical Endocrinology & Metabolism.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
The revised DSM-5-TR includes updates and clarifying modifications to the criteria sets for more than 70 disorders, updates to the descriptive text, and also examines the impact of racism and discrimination.
The revised DSM-5-TR includes updates and clarifying modifications to the criteria sets for more than 70 disorders, updates to the descriptive text, and also examines the impact of racism and discrimination.
The revised DSM-5-TR will include updates and clarifying modifications to the criteria sets for more than 70 disorders, updates to the descriptive text, and examine impacts of racism and discrimination
The revised DSM-5-TR will include updates and clarifying modifications to the criteria sets for more than 70 disorders, updates to the descriptive text, and examine impacts of racism and discrimination
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
